Araştırma Makalesi
BibTex RIS Kaynak Göster
Yıl 2021, Cilt: 38 Sayı: 4, 410 - 415, 09.10.2021

Öz

Kaynakça

  • 1. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94(4):435-438. doi:10.1093/ajcp/94.4.435
  • 2. Lam SJ, Best S, Kumar S. The impact of fibroid characteristics on pregnancy outcome. Am J Obstet Gynecol. 2014;211(4):395.e1-395.e3955. doi:10.1016/j.ajog.2014.03.066
  • 3. Milazzo GN, Catalano A, Badia V, Mallozzi M, Caserta D. Myoma and myomectomy: Poor evidence concern in pregnancy. J Obstet Gynaecol Res. 2017;43(12):1789-1804. doi:10.1111/jog.13437
  • 4. Deveer M, Deveer R, Engin-Ustun Y, et al. Comparison of pregnancy outcomes in different localizations of uterine fibroids. Clin Exp Obstet Gynecol. 2012;39(4):516-518.
  • 5. Chauhan AR. Cesarean myomectomy: necessity or opportunity? J Obstet Gynecol India. 2018;68(6):432–6. https://doi.org/10.1007/ s13224-018-1114-8.
  • 6. Sarwar I, Habib S, Bibi A, Malik N, Parveen Z. Clinical audit of foetomaternal outcome in pregnancies with fibroid uterus. J Ayub Med Coll Abbottabad. 2012;24(1):79-82.
  • 7. Warshak CR, Eskander R, Hull AD, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol. 2006;108(3 Pt 1):573-581. doi:10.1097/01.AOG.0000233155.62906.6d
  • 8. Obara M, Hatakeyama Y, Shimizu Y. Vaginal Myomectomy for Semipedunculated Cervical Myoma during Pregnancy. AJP Rep. 2014;4(1):37-40. doi:10.1055/s-0034-1370352
  • 9. Sparić R, Kadija S, Stefanović A, et al. Cesarean myomectomy in modern obstetrics: More light and fewer shadows. J Obstet Gynaecol Res. 2017;43(5):798-804. doi:10.1111/jog.13294
  • 10. Sparić R. Srp Arh Celok Lek. 2014;142(1-2):118-124. doi:10.2298/sarh1402118s
  • 11. Sparić R, Malvasi A, Tinelli A. Analysis of clinical, biological and obstetric factors influencing the decision to perform cesarean myomectomy. Ginekol Pol. 2015;86(1):40-45. doi:10.17772/gp/1897
  • 12. Sparić R, Malvasi A, Kadija S, Babović I, Nejković L, Tinelli A. Cesarean myomectomy trends and controversies: an appraisal. J Matern Fetal Neonatal Med. 2017;30(9):1114-1123. doi:10.1080/14767058.2016.1205024
  • 13. Tinelli A, Mynbaev OA, Sparic R, et al. Angiogenesis and Vascularization of Uterine Leiomyoma: Clinical Value of Pseudocapsule Containing Peptides and Neurotransmitters. Curr Protein Pept Sci. 2017;18(2):129-139. doi:10.2174/1389203717666160322150338
  • 14. Song D, Zhang W, Chames MC, Guo J. Myomectomy during cesarean delivery. Int J Gynaecol Obstet. 2013;121(3):208-213. doi:10.1016/j.ijgo.2013.01.021
  • 15. Incebiyik A, Hilali NG, Camuzcuoglu A, Vural M, Camuzcuoglu H. Myomectomy during caesarean: a retrospective evaluation of 16 cases. Arch Gynecol Obstet. 2014;289(3):569-573. doi:10.1007/s00404-013-3019-1
  • 16. Dedes I, Schäffer L, Zimmermann R, Burkhardt T, Haslinger C. Outcome and risk factors of cesarean delivery with and without cesarean myomectomy in women with uterine myomatas. Arch Gynecol Obstet. 2017;295(1):27-32. doi:10.1007/s00404-016-4177-8
  • 17. Özcan A, Kopuz A, Turan V, et al. Cesarean myomectomy for solitary uterine fibroids: Is it a safe procedure?. Ginekol Pol. 2016;87(1):54-58. doi:10.17772/gp/57833
  • 18. Kwon DH, Song JE, Yoon KR, Lee KY. The safety of cesarean myomectomy in women with large myomas. Obstet Gynecol Sci. 2014;57(5):367-372. doi:10.5468/ogs.2014.57.5.367
  • 19. Topçu HO, İskender CT, Timur H, Kaymak O, Memur T, Danışman N. Outcomes after cesarean myomectomy versus cesarean alone among pregnant women with uterine leiomyomas. Int J Gynaecol Obstet. 2015;130(3):244-246. doi:10.1016/j.ijgo.2015.03.035
  • 20. Simsek Y, Celen S, Danisman N, Mollamahmutoğlu L. Removal of uterine fibroids during cesarean section: a difficult therapeutic decision. Clin Exp Obstet Gynecol. 2012;39(1):76-78.
  • 21. Doğan S, Özyüncü Ö, Atak Z. Fibroids During Pregnancy: Effects on Pregnancy and Neonatal Outcomes. J Reprod Med. 2016;61(1-2):52-57.
  • 22. Zaima A, Ash A. Fibroid in pregnancy: characteristics, complications, and management. Postgrad Med J. 2011;87(1034):819-828. doi:10.1136/postgradmedj-2011-130319
  • 23. Roman AS, Tabsh KM. Myomectomy at time of cesarean delivery: a retrospective cohort study. BMC Pregnancy Childbirth. 2004;4(1):14. Published 2004 Jul 16. doi:10.1186/1471-2393-4-14
  • 24. Pergialiotis V, Sinanidis I, Louloudis IE, Vichos T, Perrea DN, Doumouchtsis SK. Perioperative Complications of Cesarean Delivery Myomectomy: A Meta-analysis. Obstet Gynecol. 2017;130(6):1295-1303. doi:10.1097/AOG.0000000000002342
  • 25. Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(3):211.e1-211.e2119. doi:10.1016/j.ajog.2011.12.002
  • 26. Hassiakos D, Christopoulos P, Vitoratos N, Xarchoulakou E, Vaggos G, Papadias K. Myomectomy during cesarean section: a safe procedure?. Ann N Y Acad Sci. 2006;1092:408-413. doi:10.1196/annals.1365.038
  • 27. Kaymak O, Ustunyurt E, Okyay RE, Kalyoncu S, Mollamahmutoglu L. Myomectomy during cesarean section. Int J Gynaecol Obstet. 2005;89(2):90-93. doi:10.1016/j.ijgo.2004.12.035
  • 28. Park BJ, Kim YW. Safety of cesarean myomectomy. J Obstet Gynaecol Res. 2009;35(5):906-911. doi:10.1111/j.1447-0756.2009.01121.x
  • 29. Knight J, Falcone T. Tissue extraction by morcellation: a clinical dilemma. J Minim Invasive Gynecol. 2014;21(3):319-320. doi:10.1016/j.jmig.2014.03.005

The Dilemma of Cesarean Myomectomy: Is It Safe or Not

Yıl 2021, Cilt: 38 Sayı: 4, 410 - 415, 09.10.2021

Öz

Objectives
To evaluate the safety and effectiveness of myomectomy during cesarean section
Methods
The data of fifty-four pregnants who underwent cesarean myomectomy and twenty-six pregnant with uterine leiomyoma who had cesarean section without myomectomy between the years of 2017 and 2020 in our tertiary clinic were examined retrospectively.
Results
There was no significant difference in terms of maternal age, weeks of gestation, gravida, parity, use of additional uterotonics, type of leiomyoma, size of leiomyoma, cesarean indications, blood transfusion requirement, postoperative fever, preoperative hemoglobin (g/dl), change in hemoglobin (g/dl), preoperative hematocrit (%), change in hematocrit (%), length of hospital stay between the two groups (p ˃ 0.05). While no significant difference was observed according to the location of the leiomyomas between the anterior, fundal and posterior location between the two groups, cervical leiomyomas were significantly higher in the CS group (p ˂ 0.05).
Conclusion
This study shows that cesarean myomectomy is a safe procedure in selected cases. It also offers the advantage of avoiding a second operation in patients.

Kaynakça

  • 1. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94(4):435-438. doi:10.1093/ajcp/94.4.435
  • 2. Lam SJ, Best S, Kumar S. The impact of fibroid characteristics on pregnancy outcome. Am J Obstet Gynecol. 2014;211(4):395.e1-395.e3955. doi:10.1016/j.ajog.2014.03.066
  • 3. Milazzo GN, Catalano A, Badia V, Mallozzi M, Caserta D. Myoma and myomectomy: Poor evidence concern in pregnancy. J Obstet Gynaecol Res. 2017;43(12):1789-1804. doi:10.1111/jog.13437
  • 4. Deveer M, Deveer R, Engin-Ustun Y, et al. Comparison of pregnancy outcomes in different localizations of uterine fibroids. Clin Exp Obstet Gynecol. 2012;39(4):516-518.
  • 5. Chauhan AR. Cesarean myomectomy: necessity or opportunity? J Obstet Gynecol India. 2018;68(6):432–6. https://doi.org/10.1007/ s13224-018-1114-8.
  • 6. Sarwar I, Habib S, Bibi A, Malik N, Parveen Z. Clinical audit of foetomaternal outcome in pregnancies with fibroid uterus. J Ayub Med Coll Abbottabad. 2012;24(1):79-82.
  • 7. Warshak CR, Eskander R, Hull AD, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol. 2006;108(3 Pt 1):573-581. doi:10.1097/01.AOG.0000233155.62906.6d
  • 8. Obara M, Hatakeyama Y, Shimizu Y. Vaginal Myomectomy for Semipedunculated Cervical Myoma during Pregnancy. AJP Rep. 2014;4(1):37-40. doi:10.1055/s-0034-1370352
  • 9. Sparić R, Kadija S, Stefanović A, et al. Cesarean myomectomy in modern obstetrics: More light and fewer shadows. J Obstet Gynaecol Res. 2017;43(5):798-804. doi:10.1111/jog.13294
  • 10. Sparić R. Srp Arh Celok Lek. 2014;142(1-2):118-124. doi:10.2298/sarh1402118s
  • 11. Sparić R, Malvasi A, Tinelli A. Analysis of clinical, biological and obstetric factors influencing the decision to perform cesarean myomectomy. Ginekol Pol. 2015;86(1):40-45. doi:10.17772/gp/1897
  • 12. Sparić R, Malvasi A, Kadija S, Babović I, Nejković L, Tinelli A. Cesarean myomectomy trends and controversies: an appraisal. J Matern Fetal Neonatal Med. 2017;30(9):1114-1123. doi:10.1080/14767058.2016.1205024
  • 13. Tinelli A, Mynbaev OA, Sparic R, et al. Angiogenesis and Vascularization of Uterine Leiomyoma: Clinical Value of Pseudocapsule Containing Peptides and Neurotransmitters. Curr Protein Pept Sci. 2017;18(2):129-139. doi:10.2174/1389203717666160322150338
  • 14. Song D, Zhang W, Chames MC, Guo J. Myomectomy during cesarean delivery. Int J Gynaecol Obstet. 2013;121(3):208-213. doi:10.1016/j.ijgo.2013.01.021
  • 15. Incebiyik A, Hilali NG, Camuzcuoglu A, Vural M, Camuzcuoglu H. Myomectomy during caesarean: a retrospective evaluation of 16 cases. Arch Gynecol Obstet. 2014;289(3):569-573. doi:10.1007/s00404-013-3019-1
  • 16. Dedes I, Schäffer L, Zimmermann R, Burkhardt T, Haslinger C. Outcome and risk factors of cesarean delivery with and without cesarean myomectomy in women with uterine myomatas. Arch Gynecol Obstet. 2017;295(1):27-32. doi:10.1007/s00404-016-4177-8
  • 17. Özcan A, Kopuz A, Turan V, et al. Cesarean myomectomy for solitary uterine fibroids: Is it a safe procedure?. Ginekol Pol. 2016;87(1):54-58. doi:10.17772/gp/57833
  • 18. Kwon DH, Song JE, Yoon KR, Lee KY. The safety of cesarean myomectomy in women with large myomas. Obstet Gynecol Sci. 2014;57(5):367-372. doi:10.5468/ogs.2014.57.5.367
  • 19. Topçu HO, İskender CT, Timur H, Kaymak O, Memur T, Danışman N. Outcomes after cesarean myomectomy versus cesarean alone among pregnant women with uterine leiomyomas. Int J Gynaecol Obstet. 2015;130(3):244-246. doi:10.1016/j.ijgo.2015.03.035
  • 20. Simsek Y, Celen S, Danisman N, Mollamahmutoğlu L. Removal of uterine fibroids during cesarean section: a difficult therapeutic decision. Clin Exp Obstet Gynecol. 2012;39(1):76-78.
  • 21. Doğan S, Özyüncü Ö, Atak Z. Fibroids During Pregnancy: Effects on Pregnancy and Neonatal Outcomes. J Reprod Med. 2016;61(1-2):52-57.
  • 22. Zaima A, Ash A. Fibroid in pregnancy: characteristics, complications, and management. Postgrad Med J. 2011;87(1034):819-828. doi:10.1136/postgradmedj-2011-130319
  • 23. Roman AS, Tabsh KM. Myomectomy at time of cesarean delivery: a retrospective cohort study. BMC Pregnancy Childbirth. 2004;4(1):14. Published 2004 Jul 16. doi:10.1186/1471-2393-4-14
  • 24. Pergialiotis V, Sinanidis I, Louloudis IE, Vichos T, Perrea DN, Doumouchtsis SK. Perioperative Complications of Cesarean Delivery Myomectomy: A Meta-analysis. Obstet Gynecol. 2017;130(6):1295-1303. doi:10.1097/AOG.0000000000002342
  • 25. Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(3):211.e1-211.e2119. doi:10.1016/j.ajog.2011.12.002
  • 26. Hassiakos D, Christopoulos P, Vitoratos N, Xarchoulakou E, Vaggos G, Papadias K. Myomectomy during cesarean section: a safe procedure?. Ann N Y Acad Sci. 2006;1092:408-413. doi:10.1196/annals.1365.038
  • 27. Kaymak O, Ustunyurt E, Okyay RE, Kalyoncu S, Mollamahmutoglu L. Myomectomy during cesarean section. Int J Gynaecol Obstet. 2005;89(2):90-93. doi:10.1016/j.ijgo.2004.12.035
  • 28. Park BJ, Kim YW. Safety of cesarean myomectomy. J Obstet Gynaecol Res. 2009;35(5):906-911. doi:10.1111/j.1447-0756.2009.01121.x
  • 29. Knight J, Falcone T. Tissue extraction by morcellation: a clinical dilemma. J Minim Invasive Gynecol. 2014;21(3):319-320. doi:10.1016/j.jmig.2014.03.005
Toplam 29 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Clinical Research
Yazarlar

Ali Gürsoy 0000-0001-7275-3800

Kemal Atasayan 0000-0002-4862-4352

Ezgi Doğan Tekbaş 0000-0001-7658-9198

Erdin İlter 0000-0002-4627-8628

Yayımlanma Tarihi 9 Ekim 2021
Gönderilme Tarihi 7 Ekim 2020
Kabul Tarihi 31 Aralık 2020
Yayımlandığı Sayı Yıl 2021 Cilt: 38 Sayı: 4

Kaynak Göster

APA Gürsoy, A., Atasayan, K., Tekbaş, E. D., İlter, E. (2021). The Dilemma of Cesarean Myomectomy: Is It Safe or Not. Deneysel Ve Klinik Tıp Dergisi, 38(4), 410-415.
AMA Gürsoy A, Atasayan K, Tekbaş ED, İlter E. The Dilemma of Cesarean Myomectomy: Is It Safe or Not. J. Exp. Clin. Med. Ekim 2021;38(4):410-415.
Chicago Gürsoy, Ali, Kemal Atasayan, Ezgi Doğan Tekbaş, ve Erdin İlter. “The Dilemma of Cesarean Myomectomy: Is It Safe or Not”. Deneysel Ve Klinik Tıp Dergisi 38, sy. 4 (Ekim 2021): 410-15.
EndNote Gürsoy A, Atasayan K, Tekbaş ED, İlter E (01 Ekim 2021) The Dilemma of Cesarean Myomectomy: Is It Safe or Not. Deneysel ve Klinik Tıp Dergisi 38 4 410–415.
IEEE A. Gürsoy, K. Atasayan, E. D. Tekbaş, ve E. İlter, “The Dilemma of Cesarean Myomectomy: Is It Safe or Not”, J. Exp. Clin. Med., c. 38, sy. 4, ss. 410–415, 2021.
ISNAD Gürsoy, Ali vd. “The Dilemma of Cesarean Myomectomy: Is It Safe or Not”. Deneysel ve Klinik Tıp Dergisi 38/4 (Ekim 2021), 410-415.
JAMA Gürsoy A, Atasayan K, Tekbaş ED, İlter E. The Dilemma of Cesarean Myomectomy: Is It Safe or Not. J. Exp. Clin. Med. 2021;38:410–415.
MLA Gürsoy, Ali vd. “The Dilemma of Cesarean Myomectomy: Is It Safe or Not”. Deneysel Ve Klinik Tıp Dergisi, c. 38, sy. 4, 2021, ss. 410-5.
Vancouver Gürsoy A, Atasayan K, Tekbaş ED, İlter E. The Dilemma of Cesarean Myomectomy: Is It Safe or Not. J. Exp. Clin. Med. 2021;38(4):410-5.